At FROST AND SULLIVAN, I assessed 30+ strategic growth opportunities across healthcare and life sciences, advising pharmaceutical, biotechnology, and clinical diagnostics companies on market trends and growth strategies.
I led market intelligence, competitive benchmarking, and forecasting initiatives using primary and secondary research. I also developed 3+ Growth Opportunity Newsletters and presented findings and growth roadmaps to C-level executives and global stakeholders.
At BEROE,INC, I led healthcare and Pharma R&D research engagements spanning procurement strategy, pricing and market access, commercial strategy, and new product planning. My work supported supply chain optimization and up to 10% revenue growth across client portfolios.
Earlier, at MORDORINTELLIGENCE and DATA BRIDGE MR, I conducted market intelligence and research for healthcare, pharmaceutical, and biotechnology clients. I also authored 6+ Pharma R&D thought leadership papers at BEROE,INC, including an article on AI in drug testing published by Beroe Insights in 2025.
